Table of Contents
1 Table of Contents 3
1.1 List of Tables 12
1.2 List of Figures 14
2 Introduction 17
2.1 What is this report about? 17
2.2 Definitions
17
2.2.1 In Vitro Diagnostics 17
2.2.1.1 Immunochemistry Test Reagents
17
2.2.1.2 Blood Test Reagents 17
2.2.1.3 Microbiology Test Reagents
17
2.2.1.4 Infectious Immunology Test Reagents 17
3 Company Snapshot
18
3.1 Key Information 18
3.2 Company Overview 18
3.3 Financial
Performance 18
3.4 Industry Outlook -- In Vitro Diagnostics 18
3.5
SWOT Snapshot 19
4 Business Description 20
4.1 Business Overview
20
4.2 Clinical Applications 20
4.2.1 Overview 20
4.2.2 Financials
20
4.2.3 Key Strategies 20
4.3 Industrial Applications 21
4.3.1
Overview 21
4.3.2 Financials 21
4.3.3 Market View 21
4.3.4 Key
Strategies 21
4.4 Major Products and Services 21
4.4.1 Overview 21
5 History 23
6 Business Strategy 24
6.1 Mission Statement 24
6.2
Strategy 24
6.3 Corporate Social Responsibility 24
6.3.1 Overview
24
6.3.2 Specific CSR Initiatives 24
7 Value Chain Analysis 25
7.1
Manufacturing 25
7.1.1 In House Manufacturing 25
7.2 Product
Development 26
7.2.1 Regulatory Approvals 26
7.2.2 Clinical Trials
26
7.2.3 Research and Development 26
7.3 Sales and Marketing 27
7.3.1 Partnerships and Alliances 27
7.3.2 Licensing Agreements 27
8
SWOT Analysis 28
8.1 Overview 28
8.2 bioMerieux S.A. Strengths 28
8.2.1 Strong research and development activities 28
8.2.2 Major market
player 29
8.2.3 Sharp growth of revenues 29
8.3 bioMerieux S.A.
Weaknesses 29
8.3.1 Lack of geographic diversity 29
8.3.2 Sale of
Boxtel site 29
8.3.3 Divestment of hemostasis products 29
8.4
bioMerieux S.A. Opportunities 30
8.4.1 Acquisitions 30
8.4.2 New
product launches 30
8.4.3 New subsidiaries 30
8.5 bioMerieux S.A.
Threats 30
8.5.1 Legal disputes 30
8.5.2 High competition 30
9
Competitors 32
10 bioMerieux S.A Medical Equipment Market Share Analysis
33
10.1 bioMerieux S.A,Global,Market Share (2006) 33
10.2 bioMerieux
S.A,APAC,Market Share (2006) 35
10.3 bioMerieux S.A,Europe,Market Share
(2006) 49
10.4 bioMerieux S.A,MEA,Market Share (2006) 91
10.5
bioMerieux S.A,North America,Market Share (2006) 99
10.6 bioMerieux
S.A,SCA,Market Share (2006) 105
11 Key Employees 115
12 Key Employee
Biographies 116
13 Company Statement 117
14 Locations And Subsidiaries
118
14.1 Head Office 118
14.2 Other Locations & Subsidiaries 118
15 Financial Deals Landscape 120
15.1 bioMerieux Enters Into A Partnership
Agreement With Hitachi High-Technologies 120
15.2 bioMerieux Forms Joint
Venture With Shanghai Kehua Bio-engineering 121
15.3 AdvanDx Secures $15
Million Series C Financing 123
15.4 Kestrel Capital Exits BTF 125
15.5
bioMerieux Acquires BTF From Kestrel Capital 126
15.6 Sysmex Corporation
Enters Into An Agreement With Biomerieux 127
15.7 Labtech Systems
Completes Private Placement With Biomerieux 129
15.8 Biomerieux Signs A
Licensing Agreement With Labtech Systems 130
15.9 Biomerieux Acquires
Biomedics 132
15.10 Copan Signs Distribution Agreement With biomerieux
133
15.11 Biomerieux Enters Into An Agreement With Cepheid 134
15.12
Biomerieux Enters Into An Agreement With Profos 136
15.13 bioMerieux Sells
Its Hemostasis Line Business to Trinity Biotech 137
15.14 Roche
Diagnostics Signs An Agreement With bioMerieux 139
15.15 Affymetrix Signs
An Agreement With bioMerieux 140
15.16 bioMerieux Signs An Agreement With
Applied NeuroSolutions 142
15.17 bioMerieux Signs An Agreement With
Gen-Probe 143
15.18 bioMerieux Signs An Agreement With Gen-Probe 145
15.19 bioMerieux Signs An Agreement With Eppendorf 146
15.20 Sysmex To
Form A Joint Venture With bioMerieux 148
16 Recent Developments 150
16.1 Apr 03,2008: bioMerieux,University of Sunderland Collaborate In New
Research To Improve The Identification Of Pseudomonas aeruginosa 150
16.2
Mar 17,2008: BioMerieux Enters Into Strategic Partnership With Hitachi 150
16.3 Jan 22,2008: bioMerieux Reports Q4 2007 Results 151
16.4 Jan 08,2008:
BioMerieux Transfers Certain R&D And Manufacturing Activities To France
152
16.5 Dec 13,2007: BioMerieux Opens South African Subsidiary 152
16.6 Nov 28,2007: BioMerieux Invests More Than $10 Million In Facility
Upgrades And Advanced Technology 153
16.7 Oct 26,2007: BioMerieux Declares
Q3 2007 Results 153
16.8 Sep 17,2007: BioMerieux Declares H1 2007 Results
154
16.9 Apr 23,2007: BioMerieux Declares Q1 2007 Results 156
16.10
Jan 17,2007: BioMerieux Declares Q4 2006 Results 157
16.11 Dec 19,2006:
BioMerieux Appoints New CEO 158
16.12 Sep 18,2006: BioMerieux Appoints New
Board Member 159
17 bioMerieux S.A. Pipeline Products 160
17.1 VIDAS
160
17.1.1 Product Overview 160
17.1.2 Product Description 160
17.1.3 Product Status 161
17.1.4 Product Milestone 161
17.2 mini VIDAS
161
17.2.1 Product Overview 161
17.2.2 Product Description 161
17.2.3 Product Status 162
17.3 DAVINCI 162
17.3.1 Product Overview
162
17.3.2 Product Description 162
17.3.3 Product Status 163
17.4
API 20NE 164
17.4.1 Product Overview 164
17.4.2 Product Description
164
17.4.3 Product Status 164
17.5 API NH 164
17.5.1 Product
Overview 164
17.5.2 Product Description 164
17.5.3 Product Status
165
17.6 API Staph 165
17.6.1 Product Overview 165
17.6.2 Product
Description 165
17.6.3 Product Status 165
17.7 RAPIDEC Staph 165
17.7.1 Product Overview 165
17.7.2 Product Description 165
17.7.3
Product Status 165
17.8 Slidex Staph-Kit 166
17.8.1 Product Overview
166
17.8.2 Product Description 166
17.8.3 Product Status 166
17.9
API 20 Strep 166
17.9.1 Product Overview 166
17.9.2 Product
Description 167
17.9.3 Product Status 167
17.10 API Coryne 167
17.10.1 Product Overview 167
17.10.2 Product Description 167
17.10.3
Product Status 167
17.11 Slidex Strepto-Kit 167
17.11.1 Product
Overview 167
17.11.2 Product Description 167
17.11.3 Product Status
168
17.12 API 20A 168
17.12.1 Product Overview 168
17.12.2 Product
Description 168
17.12.3 Product Status 168
17.13 NucliSENS CMV pp67
169
17.13.1 Product Overview 169
17.13.2 Product Description 169
17.13.3 Product Status 169
17.14 NucliSENS HIV-1 QT 170
17.14.1
Product Overview 170
17.14.2 Product Description 170
17.14.3 Product
Status 170
17.15 NucliSENS Basic Kit 170
17.15.1 Product Overview
170
17.15.2 Product Description 170
17.15.3 Product Status 171
17.16 NucliSENS Isolation Kit 171
17.16.1 Product Overview 171
17.16.2
Product Description 171
17.16.3 Product Status 172
17.17 API 20E
172
17.17.1 Product Overview 172
17.17.2 Product Description 172
17.17.3 Product Status 172
17.18 API Rapid 20E 172
17.18.1 Product
Overview 172
17.18.2 Product Description 173
17.18.3 Product Status
173
17.19 Rapid ID 32A 173
17.19.1 Product Overview 173
17.19.2
Product Description 173
17.19.3 Product Status 173
17.20 API 20C AUX
173
17.20.1 Product Overview 173
17.20.2 Product Description 174
17.20.3 Product Status 174
17.21 API 50 CH 174
17.21.1 Product
Overview 174
17.21.2 Product Description 174
17.21.3 Product Status
174
17.22 PSA Measurement 174
17.22.1 Product Overview 174
17.22.2
Product Description 175
17.22.3 Product Status 175
17.23 Quicker
Tuberculosis Diagnosis 175
17.23.1 Product Overview 175
17.23.2
Product Description 175
17.23.3 Product Status 175
17.24 Test for
breast cancer screening using biomarkers 176
17.24.1 Product Overview
176
17.24.2 Product Description 176
17.24.3 Product Status 176
17.25 Test for colon cancer using biomarkers 176
17.25.1 Product Overview
176
17.25.2 Product Description 176
17.25.3 Product Status 176
17.26 Test for prostate cancer using biomarkers 177
17.26.1 Product
Overview 177
17.26.2 Product Description 177
17.26.3 Product Status
177
17.27 PREVI Color Gram 177
17.27.1 Product Overview 177
17.27.2 Product Description 177
17.27.3 Product Status 178
17.27.4
Product Milestone 178
17.28 PREVI Color TB 179
17.28.1 Product
Overview 179
17.28.2 Product Description 179
17.28.3 Product Status
179
17.28.4 Product Milestone 179
18 Appendix 181
18.1 Global
Markets Direct Research Methodology 181
18.2 Coverage 182
18.3
Secondary Research 182
18.4 Primary Research 183
18.5 Models 183
18.6 Forecasts 184
18.7 Expert Panels 184
18.8 Market Revenue Chapters
184
18.8.1 Abbreviations 184
18.8.2 Currency Conversions 185
18.9
Contact Us 186
18.10 Disclaimer 186
1.1 List of Tables
Table
1: bioMerieux S.A.,Key Facts 18
Table 2: bioMerieux S.A.,SWOT
Analysis 28
Table 3: bioMerieux S.A,In Vitro Diagnostics by
Category,Global,Revenue ($ mn) and Market Share (%),2006 34
Table 4:
bioMerieux S.A,In Vitro Diagnostics by Category,APAC,Revenue ($ mn) and Market
Share (%),2006 36
Table 5: bioMerieux S.A,In Vitro Diagnostics by
Category,Australia,Revenue ($ mn) and Market Share (%),2006 38
Table 6:
bioMerieux S.A,In Vitro Diagnostics by Category,China,Revenue ($ mn) and
Market Share (%),2006 40
Table 7: bioMerieux S.A,In Vitro Diagnostics by
Category,India,Revenue ($ mn) and Market Share (%),2006 42
Table 8:
bioMerieux S.A,In Vitro Diagnostics by Category,Japan,Revenue ($ mn) and
Market Share (%),2006 44
Table 9: bioMerieux S.A,In Vitro Diagnostics by
Category,New Zealand,Revenue ($ mn) and Market Share (%),2006 46
Table 10:
bioMerieux S.A,In Vitro Diagnostics by Category,Republic of Korea,Revenue ($
mn) and Market Share (%),2006 47
Table 11: bioMerieux S.A,In Vitro
Diagnostics by Category,Taiwan,Revenue ($ mn) and Market Share (%),2006 48
Table 12: bioMerieux S.A,In Vitro Diagnostics by Category,Europe,Revenue ($
mn) and Market Share (%),2006 50
Table 13: bioMerieux S.A,In Vitro
Diagnostics by Category,Austria,Revenue ($ mn) and Market Share (%),2006
52
Table 14: bioMerieux S.A,In Vitro Diagnostics by
Category,Belgium,Revenue ($ mn) and Market Share (%),2006 54
Table 15:
bioMerieux S.A,In Vitro Diagnostics by Category,Czech Republic,Revenue ($ mn)
and Market Share (%),2006 56
Table 16: bioMerieux S.A,In Vitro Diagnostics
by Category,Finland,Revenue ($ mn) and Market Share (%),2006 58
Table 17:
bioMerieux S.A,In Vitro Diagnostics by Category,France,Revenue ($ mn) and
Market Share (%),2006 60
Table 18: bioMerieux S.A,Diabetic Care
Devices,Germany,Revenue ($ mn) and Market Share (%),2006 62
Table 19:
bioMerieux S.A,In Vitro Diagnostics by Category,Greece,Revenue ($ mn) and
Market Share (%),2006 64
Table 20: bioMerieux S.A,In Vitro Diagnostics by
Category,Hungary,Revenue ($ mn) and Market Share (%),2006 66
Table 21:
bioMerieux S.A,In Vitro Diagnostics by Category,Ireland,Revenue ($ mn) and
Market Share (%),2006 68
Table 22: bioMerieux S.A,In Vitro Diagnostics by
Category,Italy,Revenue ($ mn) and Market Share (%),2006 70
Table 23:
bioMerieux S.A,In Vitro Diagnostics by Category,Netherlands,Revenue ($ mn) and
Market Share (%),2006 72
Table 24: bioMerieux S.A,In Vitro Diagnostics by
Category,Norway,Revenue ($ mn) and Market Share (%),2006 74
Table 25:
bioMerieux S.A,In Vitro Diagnostics by Category,Poland,Revenue ($ mn) and
Market Share (%),2006 76
Table 26: bioMerieux S.A,In Vitro Diagnostics by
Category,Portugal,Revenue ($ mn) and Market Share (%),2006 78
Table 27:
bioMerieux S.A,In Vitro Diagnostics by Category,Russian Federation,Revenue ($
mn) and Market Share (%),2006 80
Table 28: bioMerieux S.A,In Vitro
Diagnostics by Category,Spain,Revenue ($ mn) and Market Share (%),2006 82
Table 29: bioMerieux S.A,In Vitro Diagnostics by Category,Sweden,Revenue ($
mn) and Market Share (%),2006 84
Table 30: bioMerieux S.A,In Vitro
Diagnostics by Category,Switzerland,Revenue ($ mn) and Market Share (%),2006
86
Table 31: bioMerieux S.A,In Vitro Diagnostics by
Category,Turkey,Revenue ($ mn) and Market Share (%),2006 88
Table 32:
bioMerieux S.A,In Vitro Diagnostics by Category,United Kingdom,Revenue ($ mn)
and Market Share (%),2006 90
Table 33: bioMerieux S.A,In Vitro Diagnostics
by Category,MEA,Revenue ($ mn) and Market Share (%),2006 92
Table 34:
bioMerieux S.A,In Vitro Diagnostics by Category,Egypt,Revenue ($ mn) and
Market Share (%),2006 94
Table 35: bioMerieux S.A,In Vitro Diagnostics by
Category,Israel,Revenue ($ mn) and Market Share (%),2006 96
Table 36:
bioMerieux S.A,In Vitro Diagnostics by Category,UAE,Revenue ($ mn) and Market
Share (%),2006 98
Table 37: bioMerieux S.A,In Vitro Diagnostics by
Category,North America,Revenue ($ mn) and Market Share (%),2006 100
Table
38: bioMerieux S.A,In Vitro Diagnostics by Category,Canada,Revenue ($ mn) and
Market Share (%),2006 102
Table 39: bioMerieux S.A,In Vitro Diagnostics by
Category,United States,Revenue ($ mn) and Market Share (%),2006 104
Table
40: bioMerieux S.A,In Vitro Diagnostics by Category,SCA,Revenue ($ mn) and
Market Share (%),2006 106
Table 41: bioMerieux S.A,In Vitro Diagnostics by
Category,Argentina,Revenue ($ mn) and Market Share (%),2006 108
Table 42:
bioMerieux S.A,In Vitro Diagnostics by Category,Brazil,Revenue ($ mn) and
Market Share (%),2006 110
Table 43: bioMerieux S.A,In Vitro Diagnostics by
Category,Chile,Revenue ($ mn) and Market Share (%),2006 112
Table 44:
bioMerieux S.A,In Vitro Diagnostics by Category,Mexico,Revenue ($ mn) and
Market Share (%),2006 114
Table 45: bioMerieux S.A.,Key Employees,
115
Table 46: bioMerieux S.A.,Subsidiaries 118
Table 47:
Abbreviations used in the Market Revenue Chapters 184
Table 48: Currency
Conversion used in the Market Revenue Chapters 185
1.2 List of
Figures
Figure 1: bioMerieux S.A.,Value Chain Analysis 25
Figure
2: bioMerieux S.A,In Vitro Diagnostics by Category,Global,Category Revenue
Share (%),2006 33
Figure 3: bioMerieux S.A,In Vitro Diagnostics by
Category,Global,Share of Market (%),2006 34
Figure 4: bioMerieux S.A,In
Vitro Diagnostics by Category,APAC,Category Revenue Share (%),2006 35
Figure 5: bioMerieux S.A,In Vitro Diagnostics by Category,APAC,Share of Market
(%),2006 36
Figure 6: bioMerieux S.A,In Vitro Diagnostics by
Category,Australia,Category Revenue Share (%),2006 37
Figure 7: bioMerieux
S.A,In Vitro Diagnostics by Category,Australia,Share of Market (%),2006 38
Figure 8: bioMerieux S.A,In Vitro Diagnostics by Category,China,Category
Revenue Share (%),2006 39
Figure 9: bioMerieux S.A,In Vitro Diagnostics by
Category,China,Share of Market (%),2006 40
Figure 10: bioMerieux S.A,In
Vitro Diagnostics by Category,India,Category Revenue Share (%),2006 41
Figure 11: bioMerieux S.A,In Vitro Diagnostics by Category,India,Share of
Market (%),2006 42
Figure 12: bioMerieux S.A,In Vitro Diagnostics by
Category,Japan,Category Revenue Share (%),2006 43
Figure 13: bioMerieux
S.A,In Vitro Diagnostics by Category,Japan,Share of Market (%),2006 44
Figure 14: bioMerieux S.A,In Vitro Diagnostics by Category,New
Zealand,Category Revenue Share (%),2006 45
Figure 15: bioMerieux S.A,In
Vitro Diagnostics by Category,New Zealand,Share of Market (%),2006 46
Figure 16: bioMerieux S.A,In Vitro Diagnostics by Category,Republic of
Korea,Share of Market (%),2006 47
Figure 17: bioMerieux S.A,In Vitro
Diagnostics by Category,Taiwan,Share of Market (%),2006 48
Figure 18:
bioMerieux S.A,In Vitro Diagnostics by Category,Europe,Category Revenue Share
(%),2006 49
Figure 19: bioMerieux S.A,In Vitro Diagnostics by
Category,Europe,Share of Market (%),2006 50
Figure 20: bioMerieux S.A,In
Vitro Diagnostics by Category,Austria,Category Revenue Share (%),2006 51
Figure 21: bioMerieux S.A,In Vitro Diagnostics by Category,Austria,Share of
Market (%),2006 52
Figure 22: bioMerieux S.A,In Vitro Diagnostics by
Category,Belgium,Category Revenue Share (%),2006 53
Figure 23: bioMerieux
S.A,In Vitro Diagnostics by Category,Belgium,Share of Market (%),2006 54
Figure 24: bioMerieux S.A,In Vitro Diagnostics by Category,Czech
Republic,Category Revenue Share (%),2006 55
Figure 25: bioMerieux S.A,In
Vitro Diagnostics by Category,Czech Republic,Share of Market (%),2006 56
Figure 26: bioMerieux S.A,In Vitro Diagnostics by Category,Finland,Category
Revenue Share (%),2006 57
Figure 27: bioMerieux S.A,In Vitro Diagnostics
by Category,Finland,Share of Market (%),2006 58
Figure 28: bioMerieux
S.A,In Vitro Diagnostics by Category,France,Category Revenue Share (%),2006
59
Figure 29: bioMerieux S.A,In Vitro Diagnostics by Category,France,Share
of Market (%),2006 60
Figure 30: bioMerieux S.A,In Vitro Diagnostics by
Category,Germany,Category Revenue Share (%),2006 61
Figure 31: bioMerieux
S.A,In Vitro Diagnostics by Category,Germany,Share of Market (%),2006 62
Figure 32: bioMerieux S.A,In Vitro Diagnostics by Category,Greece,Category
Revenue Share (%),2006 63
Figure 33: bioMerieux S.A,In Vitro Diagnostics
by Category,Greece,Share of Market (%),2006 64
Figure 34: bioMerieux
S.A,In Vitro Diagnostics by Category,Hungary,Category Revenue Share (%),2006
65
Figure 35: bioMerieux S.A,In Vitro Diagnostics by
Category,Hungary,Share of Market (%),2006 66
Figure 36: bioMerieux S.A,In
Vitro Diagnostics by Category,Ireland,Category Revenue Share (%),2006 67
Figure 37: bioMerieux S.A,In Vitro Diagnostics by Category,Ireland,Share of
Market (%),2006 68
Figure 38: bioMerieux S.A,In Vitro Diagnostics by
Category,Italy,Category Revenue Share (%),2006 69
Figure 39: bioMerieux
S.A,In Vitro Diagnostics by Category,Italy,Share of Market (%),2006 70
Figure 40: bioMerieux S.A,In Vitro Diagnostics by
Category,Netherlands,Category Revenue Share (%),2006 71
Figure 41:
bioMerieux S.A,In Vitro Diagnostics by Category,Netherlands,Share of Market
(%),2006 72
Figure 42: bioMerieux S.A,In Vitro Diagnostics by
Category,Norway,Category Revenue Share (%),2006 73
Figure 43: bioMerieux
S.A,In Vitro Diagnostics by Category,Norway,Share of Market (%),2006 74
Figure 44: bioMerieux S.A,In Vitro Diagnostics by Category,Poland,Category
Revenue Share (%),2006 75
Figure 45: bioMerieux S.A,In Vitro Diagnostics
by Category,Poland,Share of Market (%),2006 76
Figure 46: bioMerieux
S.A,In Vitro Diagnostics by Category,Portugal,Category Revenue Share (%),2006
77
Figure 47: bioMerieux S.A,In Vitro Diagnostics by
Category,Portugal,Share of Market (%),2006 78
Figure 48: bioMerieux S.A,In
Vitro Diagnostics by Category,Russian Federation,Category Revenue Share
(%),2006 79
Figure 49: bioMerieux S.A,In Vitro Diagnostics by
Category,Russian Federation,Share of Market (%),2006 80
Figure 50:
bioMerieux S.A,In Vitro Diagnostics by Category,Spain,Category Revenue Share
(%),2006 81
Figure 51: bioMerieux S.A,In Vitro Diagnostics by
Category,Spain,Share of Market (%),2006 82
Figure 52: bioMerieux S.A,In
Vitro Diagnostics by Category,Sweden,Category Revenue Share (%),2006 83
Figure 53: bioMerieux S.A,In Vitro Diagnostics by Category,Sweden,Share of
Market (%),2006 84
Figure 54: bioMerieux S.A,In Vitro Diagnostics by
Category,Switzerland,Category Revenue Share (%),2006 85
Figure 55:
bioMerieux S.A,In Vitro Diagnostics by Category,Switzerland,Share of Market
(%),2006 86
Figure 56: bioMerieux S.A,In Vitro Diagnostics by
Category,Turkey,Category Revenue Share (%),2006 87
Figure 57: bioMerieux
S.A,In Vitro Diagnostics by Category,Turkey,Share of Market (%),2006 88
Figure 58: bioMerieux S.A,In Vitro Diagnostics by Category,United
Kingdom,Category Revenue Share (%),2006 89
Figure 59: bioMerieux S.A,In
Vitro Diagnostics by Category,United Kingdom,Share of Market (%),2006 90
Figure 60: bioMerieux S.A,In Vitro Diagnostics by Category,MEA,Category
Revenue Share (%),2006 91
Figure 61: bioMerieux S.A,In Vitro Diagnostics
by Category,MEA,Share of Market (%),2006 92
Figure 62: bioMerieux S.A,In
Vitro Diagnostics by Category,Egypt,Category Revenue Share (%),2006 93
Figure 63: bioMerieux S.A,In Vitro Diagnostics by Category,Egypt,Share of
Market (%),2006 94
Figure 64: bioMerieux S.A,In Vitro Diagnostics by
Category,Israel,Category Revenue Share (%),2006 95
Figure 65: bioMerieux
S.A,In Vitro Diagnostics by Category,Israel,Share of Market (%),2006 96
Figure 66: bioMerieux S.A,In Vitro Diagnostics by Category,UAE,Category
Revenue Share (%),2006 97
Figure 67: bioMerieux S.A,In Vitro Diagnostics
by Category,UAE,Share of Market (%),2006 98
Figure 68: bioMerieux S.A,In
Vitro Diagnostics by Category,North America,Category Revenue Share (%),2006
99
Figure 69: bioMerieux S.A,In Vitro Diagnostics by Category,North
America,Share of Market (%),2006 100
Figure 70: bioMerieux S.A,In Vitro
Diagnostics by Category,Canada,Category Revenue Share (%),2006 101
Figure
71: bioMerieux S.A,In Vitro Diagnostics by Category,Canada,Share of Market
(%),2006 102
Figure 72: bioMerieux S.A,In Vitro Diagnostics by
Category,United States,Category Revenue Share (%),2006 103
Figure 73:
bioMerieux S.A,In Vitro Diagnostics by Category,United States,Share of Market
(%),2006 104
Figure 74: bioMerieux S.A,In Vitro Diagnostics by
Category,SCA,Category Revenue Share (%),2006 105
Figure 75: bioMerieux
S.A,In Vitro Diagnostics by Category,SCA,Share of Market (%),2006 106
Figure 76: bioMerieux S.A,In Vitro Diagnostics by Category,Argentina,Category
Revenue Share (%),2006 107
Figure 77: bioMerieux S.A,In Vitro Diagnostics
by Category,Argentina,Share of Market (%),2006 108
Figure 78: bioMerieux
S.A,In Vitro Diagnostics by Category,Brazil,Category Revenue Share (%),2006
109
Figure 79: bioMerieux S.A,In Vitro Diagnostics by
Category,Brazil,Share of Market (%),2006 110
Figure 80: bioMerieux S.A,In
Vitro Diagnostics by Category,Chile,Revenue ($ mn) and Market Share (%),2006
111
Figure 81: bioMerieux S.A,In Vitro Diagnostics by Category,Chile,Share
of Market (%),2006 112
Figure 82: bioMerieux S.A,In Vitro Diagnostics by
Category,Mexico,Category Revenue Share (%),2006 113
Figure 83: bioMerieux
S.A,In Vitro Diagnostics by Category,Mexico,Share of Market (%),2006 114
Figure 84: Global Markets Direct Methodology 181
View Cart
